Akebia Therapeutics to Present at Upcoming Investor Conferences
Akebia Therapeutics (Nasdaq: AKBA), a biopharmaceutical company focused on kidney disease, has announced its participation in two upcoming investor conferences in September 2024. The company's executives will attend the Wells Fargo Healthcare Conference in Boston from September 4-6 and the H.C. Wainwright 26th Annual Global Investment Conference in New York from September 9-11.
CEO John Butler will present at both events:
- Wells Fargo Healthcare Conference: Friday, September 6 at 9:30 a.m. EST
- H.C. Wainwright Global Investment Conference: Monday, September 9 at 10:30 a.m. EST (fireside chat)
Webcasts of both presentations will be available through Akebia's investor relations website for approximately 90 days following the conferences.
Akebia Therapeutics (Nasdaq: AKBA), un'azienda biofarmaceutica focalizzata sulle malattie renali, ha annunciato la sua partecipazione a due prossimi eventi per investitori a settembre 2024. I dirigenti dell'azienda parteciperanno al Wells Fargo Healthcare Conference a Boston dal 4 al 6 settembre e all'H.C. Wainwright 26th Annual Global Investment Conference a New York dal 9 all'11 settembre.
Il CEO John Butler presenterà in entrambi gli eventi:
- Wells Fargo Healthcare Conference: venerdì 6 settembre alle 9:30 EST
- H.C. Wainwright Global Investment Conference: lunedì 9 settembre alle 10:30 EST (chiacchierata informale)
I webcast di entrambe le presentazioni saranno disponibili sul sito web per i rapporti con gli investitori di Akebia per circa 90 giorni dopo le conferenze.
Akebia Therapeutics (Nasdaq: AKBA), una compañía biofarmacéutica enfocada en enfermedades renales, ha anunciado su participación en dos próximas conferencias para inversionistas en septiembre de 2024. Los ejecutivos de la compañía asistirán a la Wells Fargo Healthcare Conference en Boston del 4 al 6 de septiembre y a la H.C. Wainwright 26th Annual Global Investment Conference en Nueva York del 9 al 11 de septiembre.
El CEO John Butler presentará en ambos eventos:
- Wells Fargo Healthcare Conference: viernes, 6 de septiembre a las 9:30 a.m. EST
- H.C. Wainwright Global Investment Conference: lunes, 9 de septiembre a las 10:30 a.m. EST (charla informal)
Las transmisiones en vivo de ambas presentaciones estarán disponibles a través del sitio web de relaciones con inversionistas de Akebia durante aproximadamente 90 días después de las conferencias.
Akebia Therapeutics (Nasdaq: AKBA)는 신장 질환에 중점을 둔 생명공학 회사로, 2024년 9월에 있을 두 개의 투자자 회의에 참여한다고 발표했습니다. 회사 경영진은 9월 4일부터 6일까지 보스턴에서 열리는 웰스 파고 헬스케어 컨퍼런스와 9월 9일부터 11일까지 뉴욕에서 열리는 H.C. 웨인라이트 제26회 연례 글로벌 투자 회의에 참석할 것입니다.
CEO John Butler는 두 행사 모두에서 발표할 예정입니다:
- 웰스 파고 헬스케어 컨퍼런스: 9월 6일 금요일 오전 9시 30분 EST
- H.C. 웨인라이트 글로벌 투자 회의: 9월 9일 월요일 오전 10시 30분 EST (화로 대화)
두 발표의 웹캐스트는 Akebia의 투자자 관계 웹사이트를 통해 회의 후 약 90일 동안 제공될 것입니다.
Akebia Therapeutics (Nasdaq: AKBA), une entreprise biopharmaceutique axée sur les maladies rénales, a annoncé sa participation à deux prochaines conférences pour investisseurs en septembre 2024. Les dirigeants de l'entreprise assisteront à la Wells Fargo Healthcare Conference à Boston du 4 au 6 septembre et à la H.C. Wainwright 26th Annual Global Investment Conference à New York du 9 au 11 septembre.
Le PDG John Butler présentera lors des deux événements :
- Wells Fargo Healthcare Conference : vendredi 6 septembre à 9h30 EST
- H.C. Wainwright Global Investment Conference : lundi 9 septembre à 10h30 EST (discussion informelle)
Les webdiffusions des deux présentations seront disponibles sur le site web des relations investisseurs d'Akebia pendant environ 90 jours après les conférences.
Akebia Therapeutics (Nasdaq: AKBA), ein biopharmazeutisches Unternehmen, das sich auf Nierenerkrankungen konzentriert, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben. Die Unternehmensführung wird an der Wells Fargo Healthcare Conference in Boston vom 4. bis 6. September und an der H.C. Wainwright 26th Annual Global Investment Conference in New York vom 9. bis 11. September teilnehmen.
CEO John Butler wird bei beiden Veranstaltungen präsentieren:
- Wells Fargo Healthcare Conference: Freitag, 6. September um 9:30 Uhr EST
- H.C. Wainwright Global Investment Conference: Montag, 9. September um 10:30 Uhr EST (Feuerstelle-Gespräch)
Webcasts beider Präsentationen werden etwa 90 Tage nach den Konferenzen auf der Investor Relations-Website von Akebia verfügbar sein.
- None.
- None.
Wells Fargo Healthcare Conference
John Butler, Chief Executive Officer, will present on Friday, September 6 at 9:30 a.m. EST.
H.C. Wainwright Global Investment Conference
Mr. Butler will participate in a fireside chat on Monday, September 9 at 10:30 a.m. EST.
A webcast of each presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com following the conferences. A replay of the webcast will also be available for approximately 90 days following the conference through the Investors section of Akebia's website at https://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-upcoming-investor-conferences-302229594.html
SOURCE Akebia Therapeutics
FAQ
When is Akebia Therapeutics (AKBA) presenting at the Wells Fargo Healthcare Conference in 2024?
What investor conferences is Akebia Therapeutics (AKBA) attending in September 2024?
How can investors access Akebia Therapeutics' (AKBA) conference presentations?
What is the focus of Akebia Therapeutics (AKBA) as a biopharmaceutical company?
